Dr. Ernst von Schwarz Reports Results Of Stem Cell Study For E.D.

Beverly Hills CA

15 September, 2021

6:53 PM

Description

Cardiologist and scientist Dr. Ernst von Schwarz reports that results from a new study on stem cell therapy for erectile dysfunction (ED) show promise. The study, "Intracavernous Injection of Stem Cell-Derived Bioactive Molecules for Erectile Dysfunction — a pilot phase non-randomized controlled trial," was published Aug. 10, 2021, in the Journal of Men's Health. "This is the largest study ever performed testing allogenic stem cell injections for the treatment of sexual dysfunction, which resulted in a significant improvement of erectile dysfunction (ED)," says Dr. von Schwarz. "Stem cell therapy — even though not FDA approved — represents the most important and most promising advance in modern medicine to date.” "In this study, IIEF-5 scores improved from 12.9 ± 4.47 at baseline to 18 ± 3.37 at follow-up, which was highly significant," says Dr. von Schwarz. "More than 50% of men above the age of 50 years suffer from some degree of erectile dysfunction (ED), and there are at least 30 million men in the US diagnosed with ED.” The IIEF addresses the most relevant aspects of male sexual function including erectile strength, orgasm, desire, satisfaction with intercourse and overall satisfaction. The questionnaire has the necessary sensitivity and specificity required to detect treatment-related changes in patients with ED. Dr. von Schwarz is a triple-board-certified clinical and academic cardiologist and clinical professor of medicine at UCLA and UC Riverside. drvonschwarz.com Read the full press release here.